miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer

BACKGROUND: Bladder cancer is the most common urinary system malignancy in the United States and is characterized by its diverse prognosis and high recurrence rate. However, the molecular mechanisms underlying its progression remain unknown. Accumulating evidence suggests a critical role for miRNAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kai, Lü, Hang, Qu, Hongchen, Xie, Qingpeng, Sun, Tao, Gan, Ou, Hu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935362/
https://www.ncbi.nlm.nih.gov/pubmed/31920334
http://dx.doi.org/10.2147/OTT.S223448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935362/
https://www.ncbi.nlm.nih.gov/pubmed/31920334
http://dx.doi.org/10.2147/OTT.S223448

Ejemplares similares